1. The subject of the order is the gradual delivery of pharmaceuticals as part of drug programs to the Team of Health Care Facilities in Cieszyn.

The order consists of 7 parts, each of which is a separate subject of the contract.

2. The full range broken down by parts together with the expected demand is contained in Annex 2 to SWZ, Price Form.

3. Deliveries will take place successively during the term of the contract based on written orders placed by the Employer's Hospital Pharmacy.

4. Conditions to which supplies must correspond are contained in point III. 3. SWZ.

5. Website address of the proceedings (link leading directly to the view of the proceedings on the e-Procurement Platform):

https://ezamowienia.gov.pl/mp-client/search/list/ocds-148610-1339d2ca-4274-11ee-9aa3-96d3b4440790

6. Investigation ID: ocds-148610-1339d2ca-4274-11ee-9aa3-96d3b4440790

The subject of the contract are successive deliveries of Human Immumoglobulin. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 2 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of Interferonum beta - 1 a. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 2 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is the successive delivery of Bimekizumab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 2 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is successive deliveries of Apalutamide. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 2 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is successive deliveries of Satralizumab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 2 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract is successive deliveries of Rituximab. Full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 2 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.

The subject of the contract are successive deliveries of Dexamethasone. The full description, size, scope, type and quantity are specified in the Price Form - Appendix No. 2 to the SWZ. The conditions to be met by deliveries are set out in point III. 3. of the Terms of Reference.

The Ordering Party informs that it currently carries out and will carry out contracts with the National Health Fund under the drug programs during the duration of the contract, therefore it requires the offer of pharmaceuticals included in the List of reimbursed drugs, foods for particular nutritional uses and medical devices announced by the Minister of Health at prices not higher than the official price and within the financing limit.